Functional rescue of the nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutants G185C and R202C by a second site suppressor mutation

被引:37
作者
Schülein, R
Zühlke, K
Krause, G
Rosenthal, W
机构
[1] Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany
[2] Free Univ Berlin, Inst Pharmakol, D-14195 Berlin, Germany
关键词
D O I
10.1074/jbc.M007045200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the gene of the G protein-coupled vasopressin V-2 receptor (V-2 receptor) cause X-linked nephrogenic diabetes insipidus (NDI). Most of the missense mutations on the extracellular face of the receptor introduce additional cysteine residues. Several groups have proposed that these residues might disrupt the conserved disulfide bond of the V-2 receptor. To test this hypothesis, we first calculated a structure model of the extracellular receptor domains. The model suggests that the additional cysteine residues may form a second disulfide bond with the free, nonconserved extracellular cysteine residue Cys-195 rather than impairing the conserved bond. To address this question experimentally, we used the NDI-causing mutant receptors G185C and R202C. Their Cys-195 residues were replaced by alanine to eliminate the hypothetical second disulfide bonds. This second site mutation led to functional rescue of both NDI-causing mutant receptors, strongly suggesting that the second disulfide bonds are indeed formed. Furthermore we show that residue Cys-195, which is sensitive to "additional cysteine" mutations, is not conserved among the V-2 receptors of other species and that the presence of an uneven number of extracellular cysteine residues, as in the human V-2 receptor, is rare among class I G protein-coupled receptors.
引用
收藏
页码:8384 / 8392
页数:9
相关论文
共 26 条
[1]  
Ala Y, 1998, J AM SOC NEPHROL, V9, P1861
[2]  
BICHET DG, 1994, AM J HUM GENET, V55, P278
[3]  
CHINI B, 2000, EXP PHYSIOL, V85, P59
[4]   Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor [J].
Cotte, N ;
Balestre, MN ;
Phalipou, S ;
Hibert, M ;
Manning, M ;
Barberis, C ;
Mouillac, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29462-29468
[5]   Disulfide bridge engineering in the tachykinin NK1 receptor [J].
Elling, CE ;
Raffetseder, U ;
Nielsen, SM ;
Schwartz, TW .
BIOCHEMISTRY, 2000, 39 (04) :667-675
[6]   A personal account of the origins of a new paradigm - Epilogue [J].
Goodman, M .
MOLECULAR PHYLOGENETICS AND EVOLUTION, 1996, 5 (01) :269-285
[7]   Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg(8)] vasotocin receptor [J].
Hausmann, H ;
Richters, A ;
Kreienkamp, HJ ;
Meyerhof, W ;
Mattes, H ;
Lederis, K ;
Zwiers, H ;
Richter, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) :6907-6912
[8]   The mechanisms of aquaporin control in the renal collecting duct [J].
Klussmann, E ;
Maric, K ;
Rosenthal, W .
REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY 141, 2000, 141 :33-95
[9]  
Krause G, 2000, MOL PHARMACOL, V57, P232
[10]   The molecular basis of nephrogenic diabetes insipidus [J].
Oksche, A ;
Rosenthal, W .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (05) :326-337